Ifosfamide, mitoxantrone and etoposide (VIM) as salvage therapy of low toxicity in non-Hodgkin's lymphoma. [electronic resource]
Producer: 19951124Description: 223-7 p. digitalISSN:- 0902-4441
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow Transplantation
- Etoposide -- administration & dosage
- Female
- Humans
- Ifosfamide -- administration & dosage
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Neoplasm Staging
- Prognosis
- Recurrence
- Retrospective Studies
- Salvage Therapy
- Survival Rate
- Time Factors
- Transplantation, Autologous
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.